• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX INC. VITEK® 2 AST-P586 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX INC. VITEK® 2 AST-P586 TEST KIT Back to Search Results
Catalog Number 22276
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer from (b)(6) reported a false susceptible vancomycin result for an enterococcus strain from a patient's urine sample, in association with the vitek® 2 ast-p586 test kit (lot 3660564203).The patient was not on antibiotic therapy.The vre (vancomycin resistant enterococcus) phenotype was confirmed by pcr.The sample was also positive on chromid® vre agar.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal biomérieux investigation was initiated due to a false susceptible vancomycin (va) result associated with the vitek® 2 (v7.01) ast-p586 cards invovling an enterococcus faecium.The reference method (broth microdilution, bmd), which was the method used for vancomycin development (formulation va04n) on vitek 2 ast-p586, gave: bmd va mic > 64 mg/l r.On vitek 2 v7.01 (aes parameters : eucast + phenotypic), four (4) ast-p586 cards (one from the customer lot n°1, cl1 3660564203, one from the customer lot n°2, cl2 3660477403, one from the customer lot n°3, cl3 3660600403, and one from a random lot rl 3660410203) were tested.Cl1/cl2/cl3: va mic = 8 mg/l r with "van b like" phenotype.Rl: va mic <= 0.5 mg/l s with "wild" phenotype.The mic values on cl1, 2 and 3 were an essential agreement error compared to the reference result without category error.The false susceptible vancomycin on vitek 2 was reproduced on the rl (<=0.5 mg/l).This result is an essential agreement error comparing to the reference result leading to a very major category error.The underestimation of vancomycin on the vitek 2 ast-p586 card was confirmed in-house.This underestimation can lead to a non-detection of the van b like phenotype on rl only.A complaint and trend review were performed.No action was determined to be necessary at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-P586 TEST KIT
Type of Device
VITEK® 2 AST-P586 TEST KIT
Manufacturer (Section D)
BIOMERIEUX INC.
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX INC.
595 anglum road
st. louis MO 63042
Manufacturer Contact
debra broyles
595 anglum road
hazelwood, MO 63042
3147317301
MDR Report Key7566597
MDR Text Key110598590
Report Number1950204-2018-00209
Device Sequence Number1
Product Code LON
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K072668
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 08/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/13/2019
Device Catalogue Number22276
Device Lot Number3660564203
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received07/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/12/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-